REDEMUS

This brand name is authorized in Turkey

Active ingredients

The drug REDEMUS contains one active pharmaceutical ingredient (API):

1 Thiocolchicoside
UNII T1X8S697GT - THIOCOLCHICOSIDE

Thiocolchicoside is a semisynthetic sulphide derivative of colchicoside, showing muscle relaxant pharmacological activity. In vitro thiocolchicoside binds solely with gaba receptors and glycinergic stricnine sensitive.Tivozanib

Read about Thiocolchicoside

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M03BX05 Thiocolchicoside M Musculo-skeletal system → M03 Muscle relaxants → M03B Muscle relaxants, centrally acting agents → M03BX Other centrally acting agents
Discover more medicines within M03BX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: TR ฤฐlaรง ve Tฤฑbbi Cihaz Kurumu Identifier(s): 8698747750078

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.